Crescenta Biosciences Inc. is a small molecule drug discovery company focused on developing novel therapeutic approaches for diseases related to fatty acid metabolism. Crescenta’s discovery platform is based on a new concept that allows for the manipulation of biological functions associated with “fatty acid interacting proteins” in such a way to correct metabolic imbalance, thus providing broad therapeutic opportunities. By applying this unique platform, the company has assembled a portfolio of first-in-class drug candidates for the treatment of diseases with major unmet medical needs, particularly those related to metabolism and aging. Crescenta’s goal is to advance its pipeline into clinical development and commercialization.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 1075 Morris Ave, Union,new Jersey 07083,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- crescentabio.com
- Keywords
- Kuika Software.
- HQ
- Union, New Jersey
Crescenta Biosciences Inc. Questions
Crescenta Biosciences Inc.'s website is crescentabio.com
Crescenta Biosciences Inc.'s LinkedIn profile is https://www.linkedin.com/company/crescentabioscience
Crescenta Biosciences Inc. has
4 employees.
View email and phone details for 4
employees at Crescenta Biosciences Inc..
Crescenta Biosciences Inc.'s industry is
Biotechnology Research
Crescenta Biosciences Inc.'s top competitors are
Bat,
System Optima Inc,
Vodafone,
Aserti Pharmaceutical,
Kuika Software,
Turkcell,
Idc | Turkiye,
Aegis Biomechanics,
Crescent Bioscience,
Di̇as Teknoloji.
Crescenta Biosciences Inc.'s categories are Biotechnology Research
Crescenta Biosciences Inc.'s founding year is 2015
